CAG Repeat Expansion in THAP11 Is Associated with a Novel Spinocerebellar Ataxia
暂无分享,去创建一个
X. Bao | Hong Jiang | Yuwu Jiang | N. Zhong | Jianwen Deng | Zhao Chen | Ye Wu | H. Xiong | D. Tan | Yanbin Fan | Cui-jie Wei | Hong Zhang | Jin Xu | Yuehua Zhang | Yi-Qun Jiang | Suxia Wang | Yi-Dan Liu | Jingjing Li | Pan Liu | Yu Huang | Yuan Wu | Zhi-xiao Yang | Daojun Hong | Shuang Wang | Zheng-mao Hu
[1] A. Lang,et al. Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force – An Update , 2022, Movement disorders : official journal of the Movement Disorder Society.
[2] Lucas C. Reineke,et al. Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy , 2022, Nature Communications.
[3] D. Watkins,et al. Inherited defects of cobalamin metabolism. , 2022, Vitamins and hormones.
[4] OUP accepted manuscript , 2022, Brain Communications.
[5] N. Bonini,et al. Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence , 2021, Human molecular genetics.
[6] T. Zwaka,et al. Ronin overexpression induces cerebellar degeneration in a mouse model of ataxia , 2021, Disease models & mechanisms.
[7] H. Lv,et al. The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3 , 2021, Brain : a journal of neurology.
[8] S. Kusunoki,et al. Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan , 2021, Journal of Neurology.
[9] OUP accepted manuscript , 2021, Genome Biology and Evolution.
[10] V. Volpini,et al. A clinical report of the massive CAG repeat expansion in spinocerebellar ataxia type 2: Severe onset in a Mexican child and review previous cases , 2020, Genetics and molecular biology.
[11] A. Durr,et al. Deciphering the natural history of SCA7 in children , 2020, European journal of neurology.
[12] Y. Liang,et al. Expansion of GGC Repeat in GIPC1 Is Associated with Oculopharyngodistal Myopathy. , 2020, American journal of human genetics.
[13] G. De Michele,et al. Spinocerebellar ataxia type 48: last but not least , 2020, Neurological Sciences.
[14] W. V. van Roon-Mom,et al. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias , 2019, Neurotherapeutics.
[15] B. Tang,et al. Genetic modifiers of age-at-onset in polyglutamine diseases , 2018, Ageing Research Reviews.
[16] H. Houlden,et al. Spinocerebellar ataxia: an update , 2018, Journal of Neurology.
[17] K. Peall,et al. Dentatorubral-pallidoluysian Atrophy: An Update , 2018, Tremor and other hyperkinetic movements.
[18] H. Paulson,et al. Spinocerebellar ataxias: prospects and challenges for therapy development , 2018, Nature Reviews Neurology.
[19] C. Duyckaerts,et al. Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias , 2018, Acta neuropathologica communications.
[20] K. Xia,et al. Updated frequency analysis of spinocerebellar ataxia in China. , 2018, Brain : a journal of neurology.
[21] Pablo Mier,et al. Glutamine Codon Usage and polyQ Evolution in Primates Depend on the Q Stretch Length , 2018, Genome biology and evolution.
[22] Alexandra Silva,et al. Polyglutamine expansion diseases: More than simple repeats. , 2017, Journal of structural biology.
[23] G. Shukla,et al. Evaluation of Various Movement Disorders in Patients of Genetically Proven Spinocerebellar Ataxia: A Study from a Tertiary Care Center in Northern India , 2018, Annals of Indian Academy of Neurology.
[24] S. Macedo-Ribeiro,et al. Polyglutamine-Independent Features in Ataxin-3 Aggregation and Pathogenesis of Machado-Joseph Disease. , 2018, Advances in experimental medicine and biology.
[25] Harry T. Orr,et al. Polyglutamine spinocerebellar ataxias — from genes to potential treatments , 2017, Nature Reviews Neuroscience.
[26] Warren A. Cheung,et al. Mutations in THAP11 cause an inborn error of cobalamin metabolism and developmental abnormalities , 2017, Human molecular genetics.
[27] J. Schulman,et al. Low utilization of prenatal and pre‐implantation genetic diagnosis in Huntington disease – risk discounting in preventive genetics , 2015, Clinical genetics.
[28] T. Klockgether,et al. The preclinical stage of spinocerebellar ataxias , 2015, Neurology.
[29] D. Chakravarti,et al. Host cell factor-1 recruitment to E2F-bound and cell-cycle-control genes is mediated by THAP11 and ZNF143. , 2014, Cell reports.
[30] Biao Chen,et al. Expansion of the polyQ repeats in THAP11 forms intranuclear aggregation and causes cell G0/G1 arrest , 2014, Cell biology international.
[31] Paula Coutinho,et al. The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies , 2014, Neuroepidemiology.
[32] C. Gomez,et al. Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms , 2011, Neurology.
[33] H. Orr. Are Polyglutamine Diseases Expanding? , 2011, Neuron.
[34] Yu Kyeong Kim,et al. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. , 2007, Archives of neurology.
[35] J. Inazawa,et al. Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia , 2007, Journal of Human Genetics.
[36] M. Napierala,et al. CAG and CTG repeat polymorphism in exons of human genes shows distinct features at the expandable loci , 2007, Human mutation.
[37] R. Sinke,et al. Recent Advances in Hereditary Spinocerebellar Ataxias , 2005, Journal of neuropathology and experimental neurology.
[38] N. Pandey,et al. SMARCA2 and THAP11: potential candidates for polyglutamine disorders as evidenced from polymorphism and protein-folding simulation studies , 2004, Journal of Human Genetics.
[39] P. Vieregge,et al. Refinement of the spinocerebellar ataxia type 4 locus in a large German family and exclusion of CAG repeat expansions in this region , 2003, Journal of Neurology.
[40] Sophia Kossida,et al. The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase. , 2003, Trends in biochemical sciences.
[41] M. Patterson,et al. Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7. , 2002, American journal of medical genetics.
[42] S. Tsuji,et al. Non-Mendelian transmission in dentatorubral-pallidoluysian atrophy and Machado-Joseph disease: the mutant allele is preferentially transmitted in male meiosis. , 1996, American journal of human genetics.
[43] W. Brown,et al. Fragile X gene instability: anchoring AGGs and linked microsatellites. , 1995, American journal of human genetics.
[44] H. Zoghbi,et al. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I , 1993, Nature Genetics.
[45] A. Harding. CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.